“…As is the case for zoonotic visceral leishmaniasis (3,5,22,32,36), PCR on blood alone does not appear to be the elusive gold standard for diagnosing ACL infections in dogs (or humans). Unless a more sensitive PCR protocol (e.g., PCR-ELISA or different PCR primers) is developed to detect asymptomatic ACL infections, the use of PCR should be restricted to the diagnosis of active cases (e.g., hospitals in Europe, the United States, and elsewhere increasingly rely on PCR for Leishmania diagnosis in human patients) (6,41) and, in particular, MCL cases where common diagnostic tests (e.g., parasite culture, biopsy smears, and histopathology) are less sensitive. Nonetheless, the use of PCR on blood will have an important epidemiological application in studies monitoring the clinical and chemotherapeutic follow-up of ACL patients (10,15,34).…”